#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neoplasm malignant Familial hypertriglyceridaemia Penile cancer Bulbospinal muscular atrophy congenital Noonan syndrome Synovitis Arteriosclerosis Juvenile idiopathic arthritis Retinal dystrophy Fibrodysplasia ossificans progressiva Alpha-1 antitrypsin deficiency Haemophilia A with anti factor VIII Stiff person syndrome Mantle cell lymphoma stage IV HER2 gene amplification More trials…

    Learn about Rare Diseases

    Systemic sclerosis pulmonary Familial amyotrophic lateral sclerosis – Life with Disease Angiosarcoma non-metastatic – Life with Disease Brain stem glioma Chondrosarcoma metastatic – Diagnostics Mantle cell lymphoma refractory – Treatment Primary biliary cholangitis – Life with Disease Ocular melanoma – Life with Disease Waldenstrom’s macroglobulinaemia Hereditary neuropathic amyloidosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ianalumab Citric Acid Mk-1084 Amoxicillin Midazolam Clotrimazole Cimetidine Hydrochloride Mps-102 Perampanel Heparin Calcium Gemcitabine ADS-019 Ranolazine Dosulepin Hydrochloride CLESROVIMAB Minzasolmin Pirtobrutinib Famotidine 6QC-ICG LIPASE More therapies…

    Learn about Your Condition

    Pulmonary tuberculosis Coronary artery bypass Febrile neutropenia Respiratory tract infection Gastrointestinal melanoma Blood disorder Pulmonary alveolar haemorrhage Embolic stroke Glioblastoma Lip and/or oral cavity cancer Hyperparathyroidism primary Oropharyngeal cancer recurrent K-ras gene mutation Cardiomyopathy Mantle cell lymphoma stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on the Immune Response and Safety of a New Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Varicella
    Investigated Drugs:
    • VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED)
    • GSKVX000000025896
    • VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS
    Belgium Czechia Estonia Poland

  • Study of ibuzatrelvir tablets in non-hospitalized adults and adolescents with COVID-19 who are at high risk of developing severe illness

    Recruiting

    3 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • IBUZATRELVIR
    Belgium Bulgaria Czechia Denmark Finland Germany +2

  • Study on the Safety and Immune-Enhancing Effects of Pomalidomide in Patients with Chronic Hepatitis B Infection

    Recruiting

    1 1 1
    Investigated Diseases:
    • Hepatitis B
    Investigated Drugs:
    • Pomalidomide
    Denmark

  • Study on the Effectiveness and Safety of Chikungunya Vaccine (VLA-1553) for People at Risk of Severe Chikungunya in La Réunion

    Recruiting

    3 1 1 1
    France

  • Study of iG-Tregs for Preventing Graft-versus-Host Disease in Adults Undergoing HLA-Matched Sibling Stem Cell Transplantation

    Recruiting

    1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • IG-TREGS
    Greece

  • Study on the Safety of Intradermal mRNA COVID-19 Vaccine Bretovameran for Patients with Fibrodysplasia Ossificans Progressiva

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Fibrodysplasia ossificans progressiva
    The Netherlands
Previous Page
1 … 6 7 8 9 10 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!